NEW YORK (GenomeWeb) – Noridian Healthcare Solutions has issued a favorable final local coverage determination for NanoString Technologies' Prosigna breast cancer assay.

The LCD is effective for services provided on or after May 3. Noridian is a Medicare Administrative Contractor for two jurisdictions covering 13 Western US states, including Arizona, California, Oregon, Utah, and Washington as well as US territories in the Pacific such as Guam.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.